BioRestorative Therapies (BRTX) Other Operating Expenses (2010 - 2021)
BioRestorative Therapies' (BRTX) quarterly Other Operating Expenses came in at -$18590.0 in Q3 2021, down 155.09% YoY from $33744.0 in Q3 2020, and down 336.27% on a QoQ basis from $7868.0 in Q2 2021.
BioRestorative Therapies (BRTX) Other Operating Expenses (2010 - 2021) Analysis & Trends
BioRestorative Therapies (BRTX) has 12 years of Other Operating Expenses data on file, last reported at -$18590.0 in Q3 2021.
- Quarterly Other Operating Expenses fell 155.09% year-over-year to -$18590.0 in Q3 2021, while the trailing twelve-month figure through Jun 2022 was -$18590.0 (down 120.97% YoY) and the FY2020 annual result came in at $165531.0, down 92.59% from the prior year.
- Other Operating Expenses fell to -$18590.0 in Q3 2021, from $7868.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $884362.0 in Q2 2017 to a low of -$18590.0 in Q3 2021.
- A 5-year average of $369603.2 and a median of $473953.0 in 2018 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2017 — Other Operating Expenses jumped 60.48% — and 2021, when it tumbled 155.09%.
- Tracing BRTX's Other Operating Expenses over 5 years: stood at $491195.0 in 2017, then jumped by 50.82% to $740833.0 in 2018, then plunged by 39.86% to $445516.0 in 2019, then tumbled by 91.91% to $36055.0 in 2020, then slumped by 151.56% to -$18590.0 in 2021.
- The last three Other Operating Expenses figures came in at -$18590.0 (Q3 2021), $7868.0 (Q2 2021), and $10989.0 (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | BioRestorative Therapies | 2.00 Mn | -953,752.60 | 17,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -18,590.00 |
| Jun 30, 2021 | 7,868.00 |
| Mar 31, 2021 | 10,989.00 |
| Dec 31, 2020 | 36,055.00 |
| Sep 30, 2020 | 33,744.00 |
| Jun 30, 2020 | 39,712.00 |
| Mar 31, 2020 | 56,020.00 |
| Dec 31, 2019 | 445,516.00 |
| Sep 30, 2019 | 530,154.00 |
| Jun 30, 2019 | 642,722.00 |
| Mar 31, 2019 | 615,571.00 |
| Dec 31, 2018 | 740,833.00 |
| Sep 30, 2018 | 572,762.00 |
| Jun 30, 2018 | 435,485.00 |
| Mar 31, 2018 | 473,953.00 |
| Dec 31, 2017 | 491,195.00 |
| Sep 30, 2017 | 530,905.00 |
| Jun 30, 2017 | 884,362.00 |
| Mar 31, 2017 | 493,205.00 |
| Dec 31, 2016 | 363,511.00 |